Exposure to Non-Therapeutic INR in a High Risk Cardiovascular Patient: Potential Hazard Reduction with Genotype-guided Warfarin (Coumadin®) Dosing

Por Rodríguez-Vélez, Rosángela, Ortiz-Rivera, Oscar J., Bower, Bruce, Gorowski, Krystyna, Windemuth, Andreas, Villagra, David, Kocherla, Mohan, Seip, Richard L, D'Agostino, Darrin, Vergara, Cunegundo, Ruaño, Gualberto, Duconge, Jorge
Publicado em 2010